1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. News
  7. Summary
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
Delayed Japan Exchange  -  02:00 2022-08-18 am EDT
2016.00 JPY   -1.66%
02:30aU.S. FDA Accepts Astellas' New Drug Application for Fezolinetant
CI
08/10Verizon Business selected to transform Astellas Pharma's global network infrastructure
AQ
08/10Verizon Communications Unit Wins Network Management Contract From Astellas Pharma
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ASTELLAS PHARMA INC.
02:30aU.S. FDA Accepts Astellas' New Drug Application for Fezolinetant
CI
08/10Verizon Business selected to transform Astellas Pharma's global network infrastructure
AQ
08/09Astellas Oncology Announces Grand Prize Winner in Annual C3 Prize to Cultivate Innovati..
AQ
08/02Astellas Pharma Shares Sink 3% as Weak Yen Drags Fiscal Q1 Attributable Profit Down
MT
08/02Astellas Pharma Inc. Announces Executive Changes
CI
08/01TRANSCRIPT : Astellas Pharma Inc., Q1 2023 Earnings Call, Aug 01, 2022
CI
08/01ASTELLAS PHARMA INC. : Press Release
CO
08/01ASTELLAS PHARMA INC. : 1st quarter results
CO
07/31ASTELLAS PHARMA : Financial Results (Q1/FY2022)
PU
07/31ASTELLAS PHARMA : Presentation Material for Information Meeting (Q1/FY2022)
PU
07/31ASTELLAS PHARMA : Supplementary Documents (Q1/FY2022)
PU
07/27Astellas and Seagen Announce Positive Topline Results For PADCEV (enfortumab vedotin-ej..
AQ
07/26ASTELLAS PHARMA : and Seagen Announce Positive Topline Results For PADCEV with KEYTRUDA as..
PU
07/26Astellas and Seagen Announce Positive Topline Results For PADCEV« (enfortumab vedotin-e..
CI
07/21Astellas Pharma Inc. Unveils Plans to Open New Biotech Campus in South San Francisco
CI
More most relevant news
All news about ASTELLAS PHARMA INC.
02:30aU.S. FDA Accepts Astellas' New Drug Application for Fezolinetant
CI
08/10Verizon Business selected to transform Astellas Pharma's global network infrastructure
AQ
08/10Verizon Communications Unit Wins Network Management Contract From Astellas Pharma
MT
08/09Astellas Oncology Announces Grand Prize Winner in Annual C3 Prize to Cultivate Innovati..
AQ
08/02Astellas Pharma Shares Sink 3% as Weak Yen Drags Fiscal Q1 Attributable Profit Down
MT
08/02Astellas Pharma Inc. Announces Executive Changes
CI
08/01TRANSCRIPT : Astellas Pharma Inc., Q1 2023 Earnings Call, Aug 01, 2022
CI
08/01ASTELLAS PHARMA INC. : 1st quarter results
CO
08/01ASTELLAS PHARMA INC. : Press Release
CO
07/31ASTELLAS PHARMA : Financial Results (Q1/FY2022)
PU
More news
News in other languages on ASTELLAS PHARMA INC.
02:30aLa FDA américaine accepte la demande de nouveau médicament d'Astellas pour le fezolinet..
08/10L'unité de Verizon Communications remporte un contrat de gestion de réseau avec Astella..
08/02Les actions d'Astellas Pharma chutent de 3 %, la faiblesse du yen entraînant une baisse..
08/02Astellas Pharma Inc. annonce des changements de direction
07/27Nikkei 225 en hausse de 0,2% avant l'annonce de la Réserve fédérale
07/26MISE À JOUR SECTORIELLE : Les actions du secteur de la santé restent stables mardi avant l..
07/26Seagen et Astellas annoncent des résultats positifs pour les essais sur Padcev avec Key..
07/26Le traitement du cancer de la vessie d'Astellas-Seagen réduit la taille des tumeurs dan..
07/26Astellas et Seagen annoncent des résultats positifs pour PADCEV« (enfortumab vedotin-ej..
07/21Astellas Pharma Inc. dévoile son projet d'ouverture d'un nouveau campus biotechnologiqu..
More news
Press releases
08/10Verizon Business selected to transform Astellas Pharma's global network infrastructure
AQ
08/09Astellas Oncology Announces Grand Prize Winner in Annual C3 Prize to Cultivate Innovati..
AQ
07/31ASTELLAS PHARMA : Financial Results (Q1/FY2022)
PU
07/31ASTELLAS PHARMA : Presentation Material for Information Meeting (Q1/FY2022)
PU
07/31ASTELLAS PHARMA : Supplementary Documents (Q1/FY2022)
PU
More press releases
Upcoming event on ASTELLAS PHARMA INC.